+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID05649007

Long-Term Study of the Saphir Stem Device in Hip Replacement Surgery to Track Survival and Patient Outcomes

Led by Gruppo Bioimpianti S.r.l. · Updated on 2022-12-13

630

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research investigates the long-term performance of the Saphir femoral stem used in hip replacement surgeries for patients with hip arthropathy. The main goal is to evaluate how well the Saphir stem lasts over time, specifically measuring its survival rate at 1, 3, 5, and 10 years. Additionally, the study will assess improvements in patient function, quality of life, and safety related to the device. Participants will undergo hip arthroplasty using the Saphir femoral stem along with an acetabular cup. This post-market clinical follow-up study monitors patients receiving these devices during their primary total hip replacement surgery. The investigation will observe patients over an extended period to gather data on device performance and patient outcomes. During the study, patients will be regularly assessed to track the survival of the Saphir stem and to evaluate changes in their hip function and overall quality of life. Safety will also be monitored by recording any adverse events linked to the prosthesis. The study is expected to continue until 2036, allowing for long-term follow-up and comprehensive evaluation of the hip replacement outcomes.

CONDITIONS

Brief Title

Post-marketing Surveillance Study of the Saphir Stem in Primary Hip Surgery

Research Team

A

Alessio Vitale, Biotech

F

Fabio Stringhi, biomedic eng

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here